US2002037917A1PendingUtilityA1

Treatment of cancer using lipoic acid in combination with ascorbic acid

52
Priority: Feb 16, 1999Filed: Sep 18, 2001Published: Mar 28, 2002
Est. expiryFeb 16, 2019(expired)· nominal 20-yr term from priority
Inventors:Joseph J. CasciariNeil H. Riordan
A61K 31/385A61P 35/00
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Lipoic acid and/or its water soluble salt is used to treat cancer, alone or in combination with ascorbic acid (vitamin C). Alone or in combination, it was shown to be effective on in vitro tumors and mouse tumors. The agents can be administered safely, and have been used effectively in case studies.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method for the treatment of cancer in a mammal consisting essentially of the steps of: 
 administering to said mammal a composition consisting essentially of lipoic acid in an amount effective to slow or stop the growth of said cancer, wherein said cancer is sensitive to lipoic acid.    
     
     
         2 . The method of  claim 1 , wherein said effective amount is 100-25,000 mg/day.  
     
     
         3 . The method of  claim 1 , wherein said effective amount is 300-600 mg/day.

Join the waitlist — get patent alerts

Track US2002037917A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.